Eli Lilly have at least one repurposed drug in Phase 3 trial to treat COVID : https://investor.lilly.com/news-releases/news-release-details/lilly-begins-phase-3-clinical-trial-baricitinib-hospitalized
Baricitinib is owned by Incyte, which popped about $4B USD in MC on the news its product was being trialled. I would expect a similar pop for PAA if MPL gets to Phase 3, say $6B AUD. So my rough calculation is PAA gets to $20 a share BEFORE MPLs effectiveness is proven (or not).
THEN, I’ll know the pressure the holders of 2 million shares are feeling this weekend.
- Forums
- ASX - By Stock
- PAA
- Clinical Trials
Clinical Trials, page-301
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.98M |
Open | High | Low | Value | Volume |
18.0¢ | 18.5¢ | 18.0¢ | $1.88K | 10.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 573962 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.5¢ | 535140 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 573962 | 0.175 |
10 | 515757 | 0.170 |
5 | 157060 | 0.165 |
9 | 476304 | 0.160 |
8 | 356734 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.185 | 535140 | 8 |
0.190 | 461237 | 6 |
0.195 | 756197 | 12 |
0.200 | 307726 | 11 |
0.205 | 221875 | 2 |
Last trade - 10.08am 05/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |